Prestige Consumer Healthcare Inc. (PBH): Entry into a Material Definitive Agreement
Prestige Consumer Healthcare Inc. (PBH) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-99.1 2 exhibit991prestige-launchp.htm EX-99.1 Document Exhibit 99.1 Prestige Consumer Healthcare Inc. Announces Offering of $400 Million Senior Notes July 6, 2026 TARRYTOWN, N.Y., July 6 , 2026 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) a
How this was made
The 30-second read
Why it matters
The company intends to use proceeds (plus cash) to redeem all $400M of 5.125% senior notes due 2028 at 100% of principal plus accrued interest, contingent on completing the new issuance.
Market read
This is a concrete capital-structure event (new debt issuance + conditional redemption) that can move PBH’s credit/liquidity expectations even without equity guidance.
What to watch
The redemption is conditioned on completing an offering of at least $400M; any market disruption could delay redemption and keep leverage/refinancing risk elevated longer than expected.
Background
PBH filed an 8-K (Item 1.01/2.03) attaching a press release about a proposed private offering of senior notes by its subsidiary, Prestige Brands.
Ticker impact
PBH’s wholly owned subsidiary plans a $400M senior notes offering to redeem its $400M 5.125% 2028 notes, via a new financing condition.
Likely modest near-term volatility around deal terms/market reception; direction depends on coupon/spread versus the 2028 notes, which are not provided here.
The 8-K discloses the structure (private 144A/Reg S offering, guarantees, redemption at par plus accrued interest) but omits key pricing details (coupon/yield/spread), limiting precision on earnings/interest impact.
Market effects
Consumer healthcare issuers may see incremental refinancing activity; credit spreads and high-yield/IG demand could be marginally influenced by large new-issue supply.
Primarily US credit markets (144A/Reg S) with limited direct regional equity spillover.
Cross-border investor participation via Reg S could affect global demand for similar unsecured senior paper.
Counterpoint
If the new notes price at a meaningfully higher yield than the redeemed 2028 notes, the refinancing could increase ongoing interest burden despite the maturity extension.
Key entities
- issuerPrestige Consumer Healthcare Inc.
Parent company that guarantees the proposed notes and reports the 8-K.
- subsidiaryPrestige Brands, Inc.
Wholly owned subsidiary intending to issue up to $400M senior notes due 2034.
- debt_instrument5.125% Senior Notes due 2028
Existing notes PBH/Prestige Brands plans to redeem in full, subject to the financing condition.
- debt_instrumentSenior Notes due 2034
New unsecured senior notes proposed in a private offering, guaranteed by PBH and certain domestic subsidiaries.
